Brussels, 09/04/2015 (Agence Europe) - On Thursday 9 April, the European Commission adopted two sets of rules on the traceability of human tissue and cells for medical use.
As a result of progress in cellular and molecular biotechnology, transplants of tissue and cells have been constantly increasing. These new treatment prospects, however, bring about risks of the transmission of disease. In order to ensure “high quality and safety standards”, the Commission is setting in place a...